Related Experiment Videos
Antisera raised against the drug haloperidol
Biochemical Pharmacology
|November 15, 1985
Summary
Researchers developed antisera that bind haloperidol, a dopamine antagonist. A purified antibody subset mimics the D2 dopamine receptor
Area of Science:
- Pharmacology
- Immunology
- Neuroscience
Background:
- Haloperidol is a typical antipsychotic drug.
- Dopamine receptors, particularly D2, are key targets in treating psychosis.
- Developing tools to study drug-receptor interactions is crucial.
Purpose of the Study:
- To generate and characterize antisera against haloperidol.
- To investigate the binding properties and selectivity of these antisera.
- To explore the potential of anti-haloperidol antibodies as research tools.
Main Methods:
- Raising antisera in rabbits against haloperidol-albumin conjugates.
- Assessing antibody binding affinity and selectivity for haloperidol and related compounds.
- Partial purification of anti-haloperidol antibodies using affinity chromatography.
Main Results:
- Both antisera demonstrated high-affinity binding to haloperidol.
- The antisera exhibited differential selectivity for binding other substances.
- A purified sub-population of antibodies showed binding characteristics similar to the D2 dopamine receptor, including affinity for D2-selective antagonists.
Conclusions:
- Successfully generated specific antisera against haloperidol.
- Identified a subset of anti-haloperidol antibodies with D2 dopamine receptor-like binding properties.
- These antibodies show potential as valuable tools for studying D2 dopamine receptor pharmacology.